Common-Size Income Statement
Paying user area
Try for free
Moderna Inc. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Analysis of Solvency Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2018
- Net Profit Margin since 2018
- Return on Equity (ROE) since 2018
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Moderna Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Moderna Inc., common-size consolidated income statement
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Income statement item | Description | The company |
|---|---|---|
| Income (loss) from operations | The net result for the period of deducting operating expenses from operating revenues. | Moderna Inc. income (loss) from operations as a percentage of net product sales decreased from 2021 to 2022 and from 2022 to 2023. |
| Income (loss) before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Moderna Inc. income (loss) before income taxes as a percentage of net product sales decreased from 2021 to 2022 and from 2022 to 2023. |
| Net income (loss) | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Moderna Inc. net income (loss) as a percentage of net product sales decreased from 2021 to 2022 and from 2022 to 2023. |